Scrutinizer''s Report for 18th Annual General meeting is attached herewith.

SUPRIYA LIFESCIENCE LTD. " Creati11g true values that bind global l,ealtl, September 25, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Dalal Street, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 Mumbai- 400 001 NSE Symbol: SUPRIYA Scrip Code: 543434 Dear Sir (s), Sub: Summary of proceedings and Voting Results of the 18th Annual General Meeting Ref: Disclosure under Regulation 30 and 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith brief proceedings of the 18th Annual General Meeting (AGM) of the Company held on Thursday, September 24, 2026, at 3.00 p.m. as Annexure A. Further, pursuant to Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, we are also submitting herewith the details regarding the voting results of the business transacted at the AGM in the prescribed format along with the consolidated report of the scrutinizer as Annexure B and Annexure C respectively. All resolutions are passed with requisite majority. The Voting Results along with the Scrutinizer’s Report will be uploaded on the website of the Company i.e. www.supriyalifescience.com and on the website of NSDL i.e. www.evoting.nsdl.com. Kindly take the above-mentioned information on your records. Thanking you, Yours faithfully, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE SUPRIYA LIFESCIENCE LTD. " Creati11g true values that bind global l,ealtl, Annexure - A Summary of proceedings of the 18th Annual General Meeting The 18th Annual General Meeting (“AGM”) of the Members of Supriya Lifescience Limited (‘the Company’) was held on Thursday, September 24, 2026, at 3.00 p.m. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in accordance with various circulars issued by the Ministry of Corporate Affairs (“MCA”) and Securities and Exchange Board of India (“SEBI”) and as per the applicable provisions of the Companies Act, 2013 and Rules made thereunder. The Meeting commenced at 03.00 P.M. (IST) and concluded at 03.50 P.M. (IST). Ms. Prachi Sathe, Company Secretary, welcomed the Members at the AGM and informed that the AGM is being held through VC/OAVM in accordance with the relevant circulars issued by MCA and SEBI. The Company had also provided live webcast of the proceedings of Meeting. Further, the general instructions regarding participation in the AGM through VC/OAVM were provided to the Members. She further informed the Members that Notice of the AGM, Annual Report for FY 2025-26 as well as the Directors report along with the annexures was circulated earlier and that the said Notice along with the statutory auditors’ report, Secretarial Audit report was taken as read. Dr. Satish Wagh, Chairman & Executive Director of the Company, chaired the Meeting, however, due to medical emergency the proceedings of the AGM were taken care of by Ms. Shivani Wagh- Joint Managing Director of the Company, and after ascertaining the quorum called the meeting to order. Ms. Prachi then introduced the members of the Board attending the Meeting and in particular confirmed the presence of Mr. Hari K - Independent Director and Chairman of Audit Committee & Nomination and Remuneration Committee, Mr. Manish Panchal- Independent Director and Chairman of the Stakeholders Relationship Committee, Dr. Neelam Arora- Independent Director, Mr. Ganapati Yadav- Independent Director, Dr. Sunil Bhagwat- Independent Director, Mrs. Smita Wagh - Whole Time Director, Mr. Balasaheb Sawant- Whole Time Director, Dr. Saloni Wagh- Managing Director, Ms. Shivani Wagh- Joint Managing Director, Mr. Krishna Raghunathan- Chief Financial Officer and Ms. Prachi Sathe- Company Secretary & Compliance Officer. She further informed that the representatives of Statutory Auditors, Secretarial Auditors and Cost Auditors were also present at the AGM through VC/OAVM. She further briefed the shareholders about the facility of remote e-voting provided by the National Securities Depository Limited (NSDL) to the members of the Company. The Company had taken requisite steps to enable members to participate and vote on the items considered at the AGM. Further, the Registers under Companies Act, 2013 and other relevant documents were available for inspection. Since there was no physical attendance of members and in compliance with the Circulars issued by MCA and SEBI, the requirement of appointing proxies was not applicable. She also informed that the Company had provided the facility to cast votes electronically to those Members at the AGM, who had not casted their votes earlier. She further informed that the Board of Directors of the Company had appointed M/s. DSM & Associates, Practicing Company Secretary, as the scrutinizer for the purpose of scrutinizing votes through e-voting during the Meeting and by remote e-voting process and that he would provide the scrutinizer report in not later than 2 working days of conclusion of AGM. Thereafter, Managing Director and Joint Managing Director delivered their speech, further the speech of Chairman was also delivered by Joint Managing Director which focused on the performance of the Company in the current business scenario and future outlook of the Company. Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE SUPRIYA LIFESCIENCE LTD. " Creati11g true values that bind global l,ealtl, The following items of businesses as set out in the Notice convening the 18th AGM were transacted at the meeting: Item Business Type of Resolution Ordinary Business 1 To receive, consider, approve and adopt the Audited Financial Ordinary Statements of the Company for the financial year ended March 31, 2026, and the reports of the Board of Directors and Auditors thereon. 2 To declare a Final Dividend on Equity Shares for the Financial Year Ordinary ended March 31, 2026. 3 To appoint a Director in place of Dr. Saloni Wagh (DIN: 08491410) Ordinary who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013 and being eligible, offers herself for re-appointment. 4. To ratify the remuneration of Cost Auditors for FY 2026-27. Ordinary 5. To appoint a Director in place of Ms. Shivani Wagh (DIN: 08491420) Ordinary who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013 and being eligible, offers herself for re-appointment. The Members who had registered themselves as speaker were invited to ask questions, seek clarifications or express their views on the operations and financial performance of the Company. The Company replied to the queries raised at the AGM. Ms. Shivani then thanked the Members for their continued s [Showing first 8,000 characters — download PDF for full document]